Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$4.56B |
| 2 |
Intel
INTC
|
+$2.34B |
| 3 |
Union Pacific
UNP
|
+$1.18B |
| 4 |
Norfolk Southern
NSC
|
+$992M |
| 5 |
Wells Fargo
WFC
|
+$789M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$817M |
| 2 |
Amazon
AMZN
|
+$782M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$618M |
| 4 |
Altria Group
MO
|
+$610M |
| 5 |
Intuit
INTU
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.14% |
| 2 | Technology | 12.09% |
| 3 | Industrials | 11.31% |
| 4 | Communication Services | 11.1% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Truist Financial
TFC
$64.3B
| $699M | 0.23% |
17,341,000
+2,215,000
| +15% | +$87.6M |
|
102
Healthpeak Properties
DOC
$14.2B
| $694M | 0.23% |
20,898,472
+255,834
| +1% | +$9.31M |
|
103
Conagra Brands
CAG
$7.16B
| $663M | 0.22% |
19,496,692
-7,203,804
| -27% | -$216M |
|
104
Waste Management
WM
$90.5B
| $649M | 0.21% |
13,998,000
-5,774,800
| -29% | -$290M |
|
105
Albemarle
ALB
$15.1B
| $644M | 0.21% |
11,660,881
+194,041
| +2% | +$11.6M |
|
|
NBL
106
DELISTED
Noble Energy, Inc.
NBL
| $644M | 0.21% |
15,100,500
+7,140,839
| +90% | +$337M |
|
107
ResMed
RMD
$32.8B
| $643M | 0.21% |
11,405,500
+1,814,300
| +19% | +$115M |
|
108
International Flavors & Fragrances
IFF
$21.4B
| $634M | 0.21% |
5,802,302
+534,000
| +10% | +$61.7M |
|
109
APA Corp
APA
$14B
| $629M | 0.21% |
10,906,100
+793,200
| +8% | +$50M |
|
110
Edwards Lifesciences
EW
$53.6B
| $622M | 0.2% |
26,208,000
-21,628,200
| -45% | -$488M |
|
111
Revvity
RVTY
$13.2B
| $619M | 0.2% |
11,757,500
+832,124
| +8% | +$43.4M |
|
112
Herbalife
HLF
$1.23B
| $616M | 0.2% |
22,359,666
| – | – |
|
113
TE Connectivity
TEL
$62B
| $601M | 0.2% |
9,351,587
+454,000
| +5% | +$31.4M |
|
114
Wynn Resorts
WYNN
$10.6B
| $599M | 0.2% |
6,074,300
+701,500
| +13% | +$79.2M |
|
115
Automatic Data Processing
ADP
$107B
| $597M | 0.2% |
7,438,058
-1,622,285
| -18% | -$138M |
|
116
McDonald's
MCD
$195B
| $596M | 0.2% |
6,266,000
+2,703,000
| +76% | +$261M |
|
117
BorgWarner
BWA
$14B
| $594M | 0.2% |
11,878,243
| – | – |
|
118
Cognizant
CTSH
$26.2B
| $592M | 0.19% |
9,693,000
| – | – |
|
119
Emerson Electric
EMR
$91.4B
| $574M | 0.19% |
10,346,850
+4,560,000
| +79% | +$268M |
|
120
lululemon athletica
LULU
$13.7B
| $549M | 0.18% |
8,409,700
-1,609,500
| -16% | -$105M |
|
121
Freeport-McMoran
FCX
$96.9B
| $548M | 0.18% |
29,431,950
+4,685,000
| +19% | +$96.7M |
|
122
MGM Resorts International
MGM
$11.1B
| $547M | 0.18% |
29,971,432
+4,535,132
| +18% | +$92.1M |
|
|
TW
123
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $544M | 0.18% |
4,324,537
| – | – |
|
124
NRG Energy
NRG
$25.4B
| $543M | 0.18% |
23,748,138
+5,002,000
| +27% | +$125M |
|
|
VALE.P
125
DELISTED
Vale S A
VALE.P
| $542M | 0.18% |
107,415,435
+28,030,000
| +35% | +$157M |
|
Similar funds
Capital Research Global Investors's Q2 2015 Portfolio in Review
As of Q2 2015, Capital Research Global Investors held 466 positions worth $304B, up 4.2% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors deployed $10.5B of net new capital in Q2 2015, opening 26 new positions and adding to 162 existing holdings. Its largest new stake was Enbridge: 11,185,165 shares worth $523M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Johnson Controls International, an estimated $817M trimmed.
- Capital Research Global Investors's largest Q2 2015 buy was Enbridge: 11,185,165 shares worth $523M.
- Capital Research Global Investors added most to Alphabet (Google) Class C in Q2 2015, an estimated $4.56B increase.
- Capital Research Global Investors's biggest Q2 2015 reduction was Johnson Controls International, cutting an estimated $817M.
- Capital Research Global Investors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $618M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $304B portfolio in Q2 2015.
- Capital Research Global Investors opened 26 new positions and closed 33 in Q2 2015.
- Capital Research Global Investors's portfolio value rose 4.2% quarter-over-quarter to $304B.
Based on Capital Research Global Investors's 13F filing for Q2 2015, filed 14 Aug 2015.